Nanog siRNA (h) from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images

Nanog siRNA (h)

Be the first to write a review!

Citations:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
Nanog siRNA (h)

Description

Nanog siRNA (h)

Product Specs
ItemNanog siRNA (h)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-43958
Gene NameNanog homeobox
Quantity10 µM
Specieshuman
NCBI Full Gene NameNanog homeobox
TypesiRNA/dsRNA

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) NANOG regulates epithelial-mesenchymal transition via AMPK/mTOR signalling pathway in ovarian cancer SKOV-3 and A2780 cellsJournal of cellular and molecular medicineOctober 1, 2022Yun H, Han GH, Kim J, Chung JY, Kim JH, Cho H.

(2) siRNA-mediated silencing of Nanog reduces stemness properties and increases the sensitivity of HepG2 cells to cisplatinGeneMay 5, 2022Alemohammad H, Motafakkerazad R, Asadzadeh Z, Farsad N, Hemmat N, Najafzadeh B, Vasefifar P, Baradaran B.

(3) Nanog suppression enhanced the chemosensitivity of human non-small-cell lung cancer cells to Cisplatin and inhibited cell migrationPathology, research and practiceMay 1, 2022Najafzadeh B, Motafakkerazad R, Najafi S, Amini M, Alemohammad H, Vasefifar P, Baradaran B.

(4) PIK3R3, part of the regulatory domain of PI3K, is upregulated in sarcoma stem-like cells and promotes invasion, migration, and chemotherapy resistanceCell death & diseaseJuly 29, 2021Yoon C, Lu J, Ryeom SW, Simon MC, Yoon SS.

(5) Dysregulated miRNAs contribute to altered placental glucose metabolism in patients with gestational diabetes via targeting GLUT1 and HK2PlacentaFebruary 1, 2021Song TR, Su GD, Chi YL, Wu T, Xu Y, Chen CC.

(6) PI3K/Akt pathway and Nanog maintain cancer stem cells in sarcomasOncogenesisJanuary 19, 2021Yoon C, Lu J, Yi BC, Chang KK, Simon MC, Ryeom S, Yoon SS.

(7) Pluripotency transcription factor Nanog and its association with overall oral squamous cell carcinoma progression, cisplatin-resistance, invasion and stemness acquisitionHead & neckNovember 1, 2020Kashyap T, Nath N, Mishra P, Jha A, Nagini S, Mishra R.

(8) ERK1/2-Nanog signaling pathway enhances CD44(+) cancer stem-like cell phenotypes and epithelial-to-mesenchymal transition in head and neck squamous cell carcinomasCell death & diseaseApril 23, 2020Huang C, Yoon C, Zhou XH, Zhou YC, Zhou WW, Liu H, Yang X, Lu J, Lee SY, Huang K.

(9) Knockdown of NANOG Reduces Cell Proliferation and Induces G0/G1 Cell Cycle Arrest in Human Adipose Stem CellsInternational journal of molecular sciencesMay 26, 2019Pitrone M, Pizzolanti G, Coppola A, Tomasello L, Martorana S, Pantuso G, Giordano C.

(10) Diabetes as risk factor for pancreatic cancer: Hyperglycemia promotes epithelial-mesenchymal-transition and stem cell properties in pancreatic ductal epithelial cellsCancer lettersFebruary 28, 2018Rahn S, Zimmermann V, Viol F, Knaack H, Stemmer K, Peters L, Lenk L, Ungefroren H, Saur D, Schäfer H, et al.

(11) NANOG Plays a Hierarchical Role in the Transcription Network Regulating the Pluripotency and Plasticity of Adipose Tissue-Derived Stem CellsInternational journal of molecular sciencesMay 23, 2017Pitrone M, Pizzolanti G, Tomasello L, Coppola A, Morini L, Pantuso G, Ficarella R, Guarnotta V, Perrini S, Giorgino F, et al.

(12) Cutting Edge: NANOG Activates Autophagy under Hypoxic Stress by Binding to BNIP3L PromoterJournal of immunology (Baltimore, Md. : 1950)February 15, 2017Hasmim M, Janji B, Khaled M, Noman MZ, Louache F, Bordereaux D, Abderamane A, Baud V, Mami-Chouaib F, Chouaib S.

(13) Dichloroacetate potentiates tamoxifen-induced cell death in breast cancer cells via downregulation of the epidermal growth factor receptorOncotargetSeptember 13, 2016Woo SH, Seo SK, Park Y, Kim EK, Seong MK, Kim HA, Song JY, Hwang SG, Lee JK, Noh WC, et al.

(14) Low-dose 6-bromoindirubin-3'-oxime induces partial dedifferentiation of endothelial cells to promote increased neovascularizationStem CellsJune 1, 2014Kohler EE, Baruah J, Urao N, Ushio-Fukai M, Fukai T, Chatterjee I, Wary KK.

(15) Induced pluripotent stem cell-related genes influence biological behavior and 5-fluorouracil sensitivity of colorectal cancer cellsJournal of Zhejiang University. Science. BJanuary 1, 2012Shi Z, Bai R, Fu ZX, Zhu YL, Wang RF, Zheng S.

(16) Hypoxia-dependent inhibition of tumor cell susceptibility to CTL-mediated lysis involves NANOG induction in target cellsJournal of immunology (Baltimore, Md. : 1950)October 15, 2011Hasmim M, Noman MZ, Lauriol J, Benlalam H, Mallavialle A, Rosselli F, Mami-Chouaib F, Alcaide-Loridan C, Chouaib S.

(17) NANOG induction of fetal liver kinase-1 (FLK1) transcription regulates endothelial cell proliferation and angiogenesisBloodFebruary 3, 2011Kohler EE, Cowan CE, Chatterjee I, Malik AB, Wary KK.

(18) Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cellsPloS oneAugust 27, 2010Kong D, Banerjee S, Ahmad A, Li Y, Wang Z, Sethi S, Sarkar FH.

(19) A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25AThe Journal of cell biologyJanuary 12, 2009Zhang X, Neganova I, Przyborski S, Yang C, Cooke M, Atkinson SP, Anyfantis G, Fenyk S, Keith WN, Hoare SF, et al.

Be the First to Write a Review!